检索结果 - Michael Baltezor
- Showing 1 - 2 results of 2
-
1
<i>In silico</i> and <i>in vitro</i> drug screening identifies new therapeutic approaches for Ewing sarcoma 由 Ziyan Y. Pessetto, Bin Chen, Hani Alturkmani, Stephen Hyter, Colleen Flynn, Michael Baltezor, Yan Ma, Howard G. Rosenthal, Kathleen Neville, Scott J. Weir, Atul J. Butte, Andrew K. Godwin
出版 2016Artigo -
2
A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies 由 Stephen K. Williamson, Gary A. Johnson, Holly Maulhardt, Kathleen N. Moore, D. Scott McMeekin, Thomas K. Schulz, Gregory A. Reed, Katherine F. Roby, Christine B. Mackay, H. John Smith, Scott J. Weir, Jo Wick, Maurie Markman, Gere S. diZerega, Michael Baltezor, Jahna Espinosa, Charles J. Decedue
出版 2015Artigo
相关主题
Cancer
Internal medicine
Medicine
Ovarian cancer
Pharmacology
Adverse effect
Auranofin
Biochemistry
Biology
Biotechnology
Chemotherapy
Debulking
Dosing
Drug
Gastroenterology
Gene
In silico
In vivo
Neutropenia
Oncology
Paclitaxel
Pathology
Peritoneal cavity
Peritoneal fluid
Pharmacokinetics
Rheumatoid arthritis
Sarcoma
Surgery
Therapeutic index
Tolerability